EDITH ARAH: Open Payments
NPI 1437414174 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 9 payments from 6 companies in 2025. Trend: 2023 $179 · 2024 $533 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Neurocrine BioSciences, Inc. | 1 | $114 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Exact Sciences Corporation | 1 | $14 |
Products named: REXULTI, INGREZZA, JARDIANCE, AIRSUPRA, BREZTRI, Ozempic, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
